w66最给利老牌
w66最给利老牌:About Us
w66最给利老牌:About Sino Biopharm
w66最给利老牌:Board of Directors
w66最给利老牌:Senior Management
w66最给利老牌:R&D
R&D Team
Products
Product List
Sustainability
w66最给利老牌:ESG Governance
w66最给利老牌:ESG Management Practices
w66最给利老牌:ESG Reports
w66最给利老牌:Investors
w66最给利老牌:Information Disclosure
Corporate Governance
w66最给利老牌:Presentation
w66最给利老牌:Investor FAQ
Notices
w66最给利老牌:News
w66最给利老牌:Press Releases
w66最给利老牌:Contact
CN
EN
Investors
Home
>
w66最给利老牌:Investors
>
Corporate Governance
w66最给利老牌:
Information Disclosure
w66最给利老牌:
Corporate Governance
Presentation
w66最给利老牌:
Investor FAQ
w66最给利老牌:
Notices
Corporate Governance
Shareholder Communication Policy
2022.06.06
Dissemination of Corporate Communications
2024.01.25
Procedures for a shareholder to propose a person for election as a director
2021.07.14
1
2